| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 28, 2007
Accepted on April 4, 2007
Institut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), CNRS / INSERM / ULP; Howard Hughes Medical Institute and Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park Rd., Dallas, TX 75390, USA; Institut Clinique de la Souris, 1 Rue Laurent Fries, 67404 Illkirch, France; Hôpitaux Universitaires de Strasbourg, Laboratoire de Biochimie Générale et Spécialisée, Strasbourg, France
* To whom correspondence should be addressed. E-mail: auwerx{at}igbmc.u-strasbg.fr.
We generated and characterized a firefly luciferase reporter mouse for the nuclear receptor farnesoid X receptor (FXR). This FXR reporter mouse has basal luciferase expression in the terminal ileum, an organ with well-characterized FXR
signaling. In vivo luciferase activity reflected the diurnal activity pattern of the mouse, and is regulated by both natural (bile acids; chenodeoxycholic acid) and synthetic (GW4064) FXR
ligands. Moreover, in vivo and in vitro analysis showed luciferase activity following GW4064 administration in the liver, kidney and adrenal gland, indicating that FXR
signaling is functional in these tissues. Hepatic luciferase activity was robustly induced in cholestatic mice, showing that FXR
signaling pathways are activated in this disease. In conclusion, we have developed an FXR reporter mouse that is useful to monitor FXR
signaling in vivo in health and disease. The use of this animal could facilitate the development of new therapeutic compounds that target FXR
in a tissue-specific manner.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
C. Mataki, B. C. Magnier, S. M. Houten, J.-S. Annicotte, C. Argmann, C. Thomas, H. Overmars, W. Kulik, D. Metzger, J. Auwerx, et al. Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1 Mol. Cell. Biol., December 1, 2007; 27(23): 8330 - 8339. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |